Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Stratified therapy in Shiga toxin-producing Escherichia coli associated with hemolytic uremic syndrome.

Ashida A.

Pediatr Int. 2020 Mar;62(3):305-306. doi: 10.1111/ped.14161. No abstract available.

PMID:
32246564
2.

Clinical findings in patients with febrile seizure after 5 years of age: A retrospective study.

Ogino M, Kashiwagi M, Tanabe T, Oba C, Nomura S, Shimakawa S, Kidokoro H, Natsume J, Okumura A, Tamai H, Ashida A.

Brain Dev. 2020 Mar 19. pii: S0387-7604(20)30091-7. doi: 10.1016/j.braindev.2020.02.009. [Epub ahead of print]

PMID:
32201092
3.

Atypical Hemolytic Uremic Syndrome With the p.Ile1157Thr C3 Mutation Successfully Treated With Plasma Exchange and Eculizumab: A Case Report.

Saito D, Watanabe E, Ashida A, Kato H, Yoshida Y, Nangaku M, Ohtsuka Y, Miyata T, Hattori N, Oda S.

Crit Care Explor. 2019 Apr 17;1(4):e0008. doi: 10.1097/CCE.0000000000000008. eCollection 2019 Apr.

4.

Paraneoplastic pemphigus associated with Waldenström's macroglobulinemia.

Shirai T, Kiniwa Y, Ishii N, Hashimoto T, Senoo Y, Urushihata K, Ashida A, Okuyama R.

J Dermatol. 2020 Feb 27. doi: 10.1111/1346-8138.15289. [Epub ahead of print] No abstract available.

PMID:
32103535
5.

Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.

Mikoshiba A, Ashida A, Sakaizawa K, Kiniwa Y, Okuyama R.

J Dermatol Sci. 2020 Jan 15. pii: S0923-1811(20)30001-3. doi: 10.1016/j.jdermsci.2020.01.001. [Epub ahead of print]

PMID:
31987696
6.

Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome.

Fujii Y, Matsumura H, Yamazaki S, Shirasu A, Nakakura H, Ogihara T, Ashida A.

PLoS One. 2020 Jan 6;15(1):e0227414. doi: 10.1371/journal.pone.0227414. eCollection 2020.

7.

BRAF Mutation Heterogeneity in Melanoma Lesions.

Sakaizawa K, Ashida A, Kiniwa Y, Okuyama R.

Acta Derm Venereol. 2020 Jan 30;100(1):adv00045. doi: 10.2340/00015555-3394. No abstract available.

8.

Clinical characteristics at the renal replacement therapy initiation of Japanese pediatric patients: a nationwide cross-sectional study.

Hirano D, Inoue E, Sako M, Ashida A, Honda M, Takahashi S, Iijima K, Hattori M; Japanese Society of Pediatric Nephrology.

Clin Exp Nephrol. 2020 Jan;24(1):82-87. doi: 10.1007/s10157-019-01788-5. Epub 2019 Sep 20.

PMID:
31541336
9.

Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma.

Ashida A, Sakaizawa K, Mikoshiba A, Kiniwa Y, Okuyama R.

Acta Derm Venereol. 2019 Nov 1;99(12):1184-1185. doi: 10.2340/00015555-3279. No abstract available.

10.

Convection-Flow-Assisted Preparation of a Strong Electron Dopant, Benzyl Viologen, for Surface-Charge Transfer Doping of Molybdenum Disulfide.

Matsuyama K, Fukui A, Miura K, Ichimiya H, Aoki Y, Yamada Y, Ashida A, Yoshimura T, Fujimura N, Kiriya D.

ChemistryOpen. 2019 Jul 12;8(7):908-914. doi: 10.1002/open.201900169. eCollection 2019 Jul.

11.

Green Tea Ameliorates Hyperglycemia by Promoting the Translocation of Glucose Transporter 4 in the Skeletal Muscle of Diabetic Rodents.

Ueda-Wakagi M, Nagayasu H, Yamashita Y, Ashida AH.

Int J Mol Sci. 2019 May 16;20(10). pii: E2436. doi: 10.3390/ijms20102436.

12.

Electronic Structure Mosaicity of Monolayer Transition Metal Dichalcogenides by Spontaneous Pattern Formation of Donor Molecules.

Ichimiya H, Takinoue M, Fukui A, Yoshimura T, Ashida A, Fujimura N, Kiriya D.

ACS Appl Mater Interfaces. 2019 May 1;11(17):15922-15926. doi: 10.1021/acsami.9b03367. Epub 2019 Apr 22.

PMID:
30957480
13.

Benefits of incorporating urinary protein/creatinine ratio measurement in a school urine screening system: The experience of restructuring the school urinary screening system in Osaka Prefecture, Japan.

Ashida A, Shoji T, Honda S, Iio R, Iga C, Hayashi T, Satomura K, Tsubakihara Y.

Nephrology (Carlton). 2019 Nov;24(11):1142-1147. doi: 10.1111/nep.13558. Epub 2019 May 2.

PMID:
30635964
14.

Assessment of disease progression in dysferlinopathy: A 1-year cohort study.

Moore U, Jacobs M, James MK, Mayhew AG, Fernandez-Torron R, Feng J, Cnaan A, Eagle M, Bettinson K, Rufibach LE, Lofra RM, Blamire AM, Carlier PG, Mittal P, Lowes LP, Alfano L, Rose K, Duong T, Berry KM, Montiel-Morillo E, Pedrosa-Hernández I, Holsten S, Sanjak M, Ashida A, Sakamoto C, Tateishi T, Yajima H, Canal A, Ollivier G, Decostre V, Mendez JB, Sánchez-Aguilera Praxedes N, Thiele S, Siener C, Shierbecker J, Florence JM, Vandevelde B, DeWolf B, Hutchence M, Gee R, Prügel J, Maron E, Hilsden H, Lochmüller H, Grieben U, Spuler S, Tesi Rocha C, Day JW, Jones KJ, Bharucha-Goebel DX, Salort-Campana E, Harms M, Pestronk A, Krause S, Schreiber-Katz O, Walter MC, Paradas C, Hogrel JY, Stojkovic T, Takeda S, Mori-Yoshimura M, Bravver E, Sparks S, Díaz-Manera J, Bello L, Semplicini C, Pegoraro E, Mendell JR, Bushby K, Straub V; Jain COS Consortium.

Neurology. 2019 Jan 9. pii: 10.1212/WNL.0000000000006858. doi: 10.1212/WNL.0000000000006858. [Epub ahead of print]

15.

Effect of Systematic Conversion to Generic Mycophenolate Mofetil (MMF) in Kidney Transplantation: A Single-Center Clinical Experience from Japan.

Hirano H, Matsunaga T, Maenosono R, Taniguchi S, Uehara H, Nomi H, Kano Y, Fujiwara Y, Ichihashi A, Kobayashi D, Tsutsumi T, Komura K, Ibuki N, Inamoto T, Matsumura H, Ashida A, Azuma H.

Transplant Proc. 2018 Dec;50(10):3255-3257. doi: 10.1016/j.transproceed.2018.04.064. Epub 2018 May 4.

PMID:
30577194
16.

Tuning Transition-Metal Dichalcogenide Field-Effect Transistors by Spontaneous Pattern Formation of an Ultrathin Molecular Dopant Film.

Ichimiya H, Takinoue M, Fukui A, Miura K, Yoshimura T, Ashida A, Fujimura N, Kiriya D.

ACS Nano. 2018 Oct 23;12(10):10123-10129. doi: 10.1021/acsnano.8b04914. Epub 2018 Sep 24.

PMID:
30216040
17.

Systematic Study of Photoluminescence Enhancement in Monolayer Molybdenum Disulfide by Acid Treatment.

Kiriya D, Hijikata Y, Pirillo J, Kitaura R, Murai A, Ashida A, Yoshimura T, Fujimura N.

Langmuir. 2018 Sep 4;34(35):10243-10249. doi: 10.1021/acs.langmuir.8b01425. Epub 2018 Aug 24.

PMID:
30099877
18.

Strong Association of the HLA-DR/DQ Locus with Childhood Steroid-Sensitive Nephrotic Syndrome in the Japanese Population.

Jia X, Horinouchi T, Hitomi Y, Shono A, Khor SS, Omae Y, Kojima K, Kawai Y, Nagasaki M, Kaku Y, Okamoto T, Ohwada Y, Ohta K, Okuda Y, Fujimaru R, Hatae K, Kumagai N, Sawanobori E, Nakazato H, Ohtsuka Y, Nakanishi K, Shima Y, Tanaka R, Ashida A, Kamei K, Ishikura K, Nozu K, Tokunaga K, Iijima K; Research Consortium on Genetics of Childhood Idiopathic Nephrotic Syndrome in Japan.

J Am Soc Nephrol. 2018 Aug;29(8):2189-2199. doi: 10.1681/ASN.2017080859. Epub 2018 Jul 16.

19.

Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.

Horinouchi T, Nozu K, Yamamura T, Minamikawa S, Omori T, Nakanishi K, Fujimura J, Ashida A, Kitamura M, Kawano M, Shimabukuro W, Kitabayashi C, Imafuku A, Tamagaki K, Kamei K, Okamoto K, Fujinaga S, Oka M, Igarashi T, Miyazono A, Sawanobori E, Fujimaru R, Nakanishi K, Shima Y, Matsuo M, Ye MJ, Nozu Y, Morisada N, Kaito H, Iijima K.

J Am Soc Nephrol. 2018 Aug;29(8):2244-2254. doi: 10.1681/ASN.2018030228. Epub 2018 Jun 29.

20.

A consensus statement on health-care transition of patients with childhood-onset chronic kidney diseases: providing adequate medical care in adolescence and young adulthood.

Kubota W, Honda M, Okada H, Hattori M, Iwano M, Akioka Y, Ashida A, Kawasaki Y, Kiyomoto H, Sako M, Terada Y, Hirano D, Fujieda M, Fujimoto S, Masaki T, Ito S, Uemura O, Gotoh Y, Komatsu Y, Nishi S, Maru M, Narita I, Maruyama S.

Clin Exp Nephrol. 2018 Aug;22(4):743-751. doi: 10.1007/s10157-018-1589-8. Epub 2018 Jun 4. Review. No abstract available.

PMID:
29869191
21.

Clinical features in a series of 258 Japanese pediatric patients with thrombotic microangiopathy.

Ashida A, Matsumura H, Sawai T, Fujimaru R, Fujii Y, Shirasu A, Nakakura H, Iijima K.

Clin Exp Nephrol. 2018 Aug;22(4):924-930. doi: 10.1007/s10157-018-1531-0. Epub 2018 Jan 19.

PMID:
29352455
22.

Microvascular endothelial function in Japanese early adolescents.

Odanaka Y, Takitani K, Katayama H, Fujiwara H, Kishi K, Ozaki N, Ashida A, Takaya R, Tamai H.

J Clin Biochem Nutr. 2017 Nov;61(3):228-232. doi: 10.3164/jcbn.17-58. Epub 2017 Oct 19.

23.

Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients.

Ashida A, Sakaizawa K, Uhara H, Okuyama R.

Acta Derm Venereol. 2017 Nov 15;97(10):1212-1218. doi: 10.2340/00015555-2748.

24.

Influences of FLU/BU and FLU/MEL on incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients.

Torihata S, Mukai T, Uchihashi T, Matsunaga K, Miki H, Yasumoto M, Yasutake N, Ashida A, Enomoto A, Hamada S, Ashida T.

Rinsho Ketsueki. 2017;58(3):197-203. doi: 10.11406/rinketsu.58.197. Japanese.

PMID:
28381685
25.

A case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome
.

Ashida A, Fujii Y, Matsumura H, Tamai H.

Int J Clin Pharmacol Ther. 2017 Mar;55(3):264-269. doi: 10.5414/CP202732.

PMID:
27936525
26.

Distinct phenotype of epidermolysis bullosa simplex with infantile migratory circinate erythema due to frameshift mutations in the V2 domain of KRT5.

Kumagai Y, Umegaki-Arao N, Sasaki T, Nakamura Y, Takahashi H, Ashida A, Tsunemi Y, Kawashima M, Shimizu A, Ishiko A, Nakamura K, Tsuchihashi H, Amagai M, Kubo A.

J Eur Acad Dermatol Venereol. 2017 May;31(5):e241-e243. doi: 10.1111/jdv.14005. Epub 2016 Nov 2. No abstract available.

PMID:
27730678
27.

DNA-Templated Synthesis of Perylenediimide Stacks Utilizing Abasic Sites as Binding Pockets and Reactive Sites.

Takada T, Ido M, Ashida A, Nakamura M, Yamana K.

Chembiochem. 2016 Dec 2;17(23):2230-2233. doi: 10.1002/cbic.201600454. Epub 2016 Oct 14.

PMID:
27739646
28.

Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma.

Sakaizawa K, Ashida A, Uhara H, Okuyama R.

Clin Chem Lab Med. 2017 Mar 1;55(4):e92-e95. doi: 10.1515/cclm-2016-0634. No abstract available.

PMID:
27665423
29.

Clinical guides for atypical hemolytic uremic syndrome in Japan.

Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, Hidaka Y, Kaname S, Maruyama S, Yasuda T, Yoshida Y, Ito S, Hattori M, Miyakawa Y, Fujimura Y, Okada H, Kagami S; Joint Committee for the Revision of Clinical Guides of Atypical Hemolytic Uremic Syndrome in Japan.

Pediatr Int. 2016 Jul;58(7):549-55. doi: 10.1111/ped.13044.

PMID:
27460397
30.

Spectrum of LMX1B mutations: from nail-patella syndrome to isolated nephropathy.

Harita Y, Kitanaka S, Isojima T, Ashida A, Hattori M.

Pediatr Nephrol. 2017 Oct;32(10):1845-1850. doi: 10.1007/s00467-016-3462-x. Epub 2016 Jul 23. Review.

PMID:
27450397
31.

Clinical guides for atypical hemolytic uremic syndrome in Japan.

Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, Hidaka Y, Kaname S, Maruyama S, Yasuda T, Yoshida Y, Ito S, Hattori M, Miyakawa Y, Fujimura Y, Okada H, Kagami S; Joint Committee for the Revision of Clinical Guides of Atypical Hemolytic Uremic Syndrome in Japan.

Clin Exp Nephrol. 2016 Aug;20(4):536-543. doi: 10.1007/s10157-016-1276-6.

PMID:
27422619
32.

A pure chloride channel mutant of CLC-5 causes Dent's disease via insufficient V-ATPase activation.

Satoh N, Yamada H, Yamazaki O, Suzuki M, Nakamura M, Suzuki A, Ashida A, Yamamoto D, Kaku Y, Sekine T, Seki G, Horita S.

Pflugers Arch. 2016 Jul;468(7):1183-1196. doi: 10.1007/s00424-016-1808-7. Epub 2016 Apr 5.

PMID:
27044412
33.

Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR.

Ashida A, Sakaizawa K, Mikoshiba A, Uhara H, Okuyama R.

Int J Clin Oncol. 2016 Oct;21(5):981-988. Epub 2016 Apr 4.

PMID:
27041702
34.

Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan.

Hattori M, Iwano M, Sako M, Honda M, Okada H, Akioka Y, Ashida A, Kawasaki Y, Kiyomoto H, Terada Y, Hirano D, Fujieda M, Fujimoto S, Masaki T, Maruyama S, Mastuo S.

Clin Exp Nephrol. 2016 Dec;20(6):918-925. doi: 10.1007/s10157-016-1231-6. Epub 2016 Jan 19.

PMID:
26780894
35.

Acquired epidermodysplasia verruciformis associated with human papillomavirus type 47 in a HIV-infected patient.

Ashida A, Shimizu A, Okuyama R.

J Dermatol. 2016 Jun;43(6):717-8. doi: 10.1111/1346-8138.13262. Epub 2016 Jan 18. No abstract available.

PMID:
26778636
36.

Inhibition of epidermal growth factor receptor induces tumor necrosis factor-α via activation of peroxisome proliferator-activated receptor-γ and nuclear factor-κB in sebocytes: A possible pathogenesis of papulopustular rash.

Ashida A, Ogawa E, Uhara H, Koizumi T, Okuyama R.

J Dermatol Sci. 2016 Apr;82(1):53-6. doi: 10.1016/j.jdermsci.2015.12.004. Epub 2015 Dec 17. No abstract available.

PMID:
26742624
37.

Targeted temperature management for acute encephalopathy in a Japanese secondary emergency medical care hospital.

Murata S, Kashiwagi M, Tanabe T, Oba C, Shigehara S, Yamazaki S, Ashida A, Sirasu A, Inoue K, Okasora K, Tamai H.

Brain Dev. 2016 Mar;38(3):317-23. doi: 10.1016/j.braindev.2015.09.003. Epub 2015 Sep 26.

PMID:
26415547
38.

Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer.

Ohashi A, Minagawa A, Ashida A, Koga H, Uhara H, Okuyama R.

J Dermatol. 2015 Dec;42(12):1198-9. doi: 10.1111/1346-8138.13085. Epub 2015 Aug 29. No abstract available.

PMID:
26333146
39.

Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients.

Sakaizawa K, Ashida A, Uchiyama A, Ito T, Fujisawa Y, Ogata D, Matsushita S, Fujii K, Fukushima S, Shibayama Y, Hatta N, Takenouchi T, Uehara J, Okuyama R, Yamazaki N, Uhara H.

J Dermatol Sci. 2015 Oct;80(1):33-7. doi: 10.1016/j.jdermsci.2015.07.012. Epub 2015 Jul 26.

PMID:
26282084
40.

Melanoma with BRAF Mutation in Circulating Cell-free DNA despite no Mutation in the Primary Lesion: A Case Report.

Ashida A, Uhara H, Mikoshiba A, Sakaizawa K, Kumagai N, Koga H, Okuyama R.

Acta Derm Venereol. 2016 Jan;96(1):128-9. doi: 10.2340/00015555-2194. No abstract available.

41.

Autoimmune-type atypical hemolytic uremic syndrome treated with eculizumab as first-line therapy.

Hisano M, Ashida A, Nakano E, Suehiro M, Yoshida Y, Matsumoto M, Miyata T, Fujimura Y, Hattori M.

Pediatr Int. 2015 Apr;57(2):313-7. doi: 10.1111/ped.12469.

PMID:
25868950
42.

Clinical characteristics of rotavirus gastroenteritis with urinary crystals.

Shirasu A, Ashida A, Matsumura H, Nakakura H, Tamai H.

Pediatr Int. 2015 Oct;57(5):917-21. doi: 10.1111/ped.12626. Epub 2015 Jul 6.

PMID:
25810216
43.

Photocurrent generation through charge-transfer processes in noncovalent perylenediimide/DNA complexes.

Takada T, Ido M, Ashida A, Nakamura M, Fujitsuka M, Kawai K, Majima T, Yamana K.

Chemistry. 2015 Apr 27;21(18):6846-51. doi: 10.1002/chem.201406592. Epub 2015 Mar 17.

PMID:
25784217
44.

End-stage renal disease in Japanese children: a nationwide survey during 2006-2011.

Hattori M, Sako M, Kaneko T, Ashida A, Matsunaga A, Igarashi T, Itami N, Ohta T, Gotoh Y, Satomura K, Honda M, Igarashi T.

Clin Exp Nephrol. 2015 Oct;19(5):933-8. doi: 10.1007/s10157-014-1077-8. Epub 2015 Jan 17.

PMID:
25595442
45.

Differential diagnosis of delirious behavior in children with influenza.

Kashiwagi M, Tanabe T, Ooba C, Masuda M, Shigehara S, Murata S, Ashida A, Shirasu A, Inoue K, Okasora K, Tamai H.

Brain Dev. 2015 Jun;37(6):618-24. doi: 10.1016/j.braindev.2014.09.003. Epub 2014 Sep 29.

PMID:
25277296
46.

Toll-like receptor 4 signaling promotes the migration of human melanoma cells.

Takazawa Y, Kiniwa Y, Ogawa E, Uchiyama A, Ashida A, Uhara H, Goto Y, Okuyama R.

Tohoku J Exp Med. 2014 Sep;234(1):57-65.

47.

Guidelines for the management and investigation of hemolytic uremic syndrome.

Igarashi T, Ito S, Sako M, Saitoh A, Hataya H, Mizuguchi M, Morishima T, Ohnishi K, Kawamura N, Kitayama H, Ashida A, Kaname S, Taneichi H, Tang J, Ohnishi M; Study group for establishing guidelines for the diagnosis and therapy of hemolytic uremic syndrome.

Clin Exp Nephrol. 2014 Aug;18(4):525-57. doi: 10.1007/s10157-014-0995-9. Review. No abstract available.

PMID:
25099085
48.

Photocurrent generation enhanced by charge delocalization over stacked perylenediimide chromophores assembled within DNA.

Takada T, Ashida A, Nakamura M, Fujitsuka M, Majima T, Yamana K.

J Am Chem Soc. 2014 May 14;136(19):6814-7. doi: 10.1021/ja501535z. Epub 2014 May 1.

PMID:
24786843
49.

Coexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinoma.

Okada T, Nakamura T, Watanabe T, Onoda N, Ashida A, Okuyama R, Ito K.

PLoS One. 2014 Apr 11;9(4):e94487. doi: 10.1371/journal.pone.0094487. eCollection 2014.

50.

Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society.

Sawai T, Nangaku M, Ashida A, Fujimaru R, Hataya H, Hidaka Y, Kaname S, Okada H, Sato W, Yasuda T, Yoshida Y, Fujimura Y, Hattori M, Kagami S.

Pediatr Int. 2014 Feb;56(1):1-5. doi: 10.1111/ped.12274. Review.

PMID:
24548192

Supplemental Content

Loading ...
Support Center